Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human EGFR/ERBB1/HER1 Protein, N-His

Recombinant Human EGFR/ERBB1/HER1 Protein, N-His from ProteoGenix; catalogue ARO-P10400; research use only.

SKU:
ABM140841-1
Manufacturer SKU
ARO-P10400
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction

Recombinant Human EGFR/ERBB1/HER1 Protein, also known as Epidermal Growth Factor Receptor, is a transmembrane protein that plays a crucial role in cell growth and proliferation. It is a member of the ErbB family of receptors and is activated by binding to its ligand, epidermal growth factor (EGF). This protein has been extensively studied and its structure, activity, and applications have been well characterized. In this article, we will provide a comprehensive overview of Recombinant Human EGFR/ERBB1/HER1 Protein, highlighting its structure, activity, and various applications in the field of biotechnology and medicine.

Structure of Recombinant Human EGFR/ERBB1/HER1 Protein

Recombinant Human EGFR/ERBB1/HER1 Protein is a 170-kDa transmembrane glycoprotein composed of 1186 amino acids. It consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain contains four subdomains, namely I, II, III, and IV, which are responsible for ligand binding. The transmembrane domain anchors the protein to the cell membrane, while the intracellular domain contains a tyrosine kinase domain that is responsible for downstream signaling.

Activity of Recombinant Human EGFR/ERBB1/HER1 Protein

Recombinant Human EGFR/ERBB1/HER1 Protein is a receptor tyrosine kinase that is activated by binding to its ligand, EGF. Upon ligand binding, the receptor undergoes a conformational change, leading to the activation of its tyrosine kinase domain. This results in the autophosphorylation of specific tyrosine residues on the intracellular domain, which serves as docking sites for various downstream signaling molecules. These signaling pathways ultimately lead to cell proliferation, differentiation, and survival.

Applications of Recombinant Human EGFR/ERBB1/HER1 Protein

Recombinant Protein Production

Recombinant Human EGFR/ERBB1/HER1 Protein is widely used in the production of recombinant proteins. Its high affinity for EGF allows for efficient purification of the protein using affinity chromatography. This makes it an ideal choice for the production of recombinant proteins for various applications, including drug discovery and development.

Antigen for Antibody Production

Recombinant Human EGFR/ERBB1/HER1 Protein is also used as an antigen for the production of antibodies. Due to its role in cell proliferation and its overexpression in various cancers, it has been extensively studied as a potential target for cancer therapy. Antibodies against this protein have been developed and are used for diagnostic and therapeutic purposes in cancer treatment.

Cancer Research

Recombinant Human EGFR/ERBB1/HER1 Protein is a crucial tool in cancer research. Its overexpression has been linked to various types of cancer, including lung, breast, and colorectal cancer. Recombinant protein is used to study the mechanisms of EGFR signaling in cancer cells and to develop targeted therapies for these cancers. It is also used in preclinical studies to evaluate the efficacy of potential anti-cancer drugs.

Drug Development

Recombinant Human EGFR/ERBB1/HER1 Protein has been a target for drug development due to its role in cancer and other diseases. Several drugs have been developed that target this protein, including monoclonal antibodies and tyrosine kinase inhibitors. These drugs have shown promising results in clinical trials and have been approved for the treatment of various cancers, such as non-small cell lung cancer and metastatic colorectal cancer.

Diagnostic Applications

Recombinant Human EGFR

ProteoGenix catalogue number ARO-P10400. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 16.87 kDa; Fragment: Leu25-Ser151; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
HER1, Receptor tyrosine-protein kinase erbB-1, Proto-oncogene c-ErbB-1, Epidermal growth factor receptor, EGFR, ERBB1, ERBB
Host species
E. coli
Source organism
Human
Molecular weight
16.87 kDa
Sequence fragment
Leu25-Ser151
Sequence
LEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFS
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P10400
UniProt accession
P00533
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£239.00£191.20